Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study groupAntonio Bertolotto, Simona Malucchi, Ruggero Capra et al.|Neurological Sciences|2013Cited by 37
Erratum to: Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study groupAntonio Bertolotto, Simona Malucchi, Marco Capobianco et al.|Neurological Sciences|2014Cited by 2